306 related articles for article (PubMed ID: 17962072)
1. Target assessment for antiparasitic drug discovery.
Frearson JA; Wyatt PG; Gilbert IH; Fairlamb AH
Trends Parasitol; 2007 Dec; 23(12):589-95. PubMed ID: 17962072
[TBL] [Abstract][Full Text] [Related]
2. The changing landscape of antiparasitic drug discovery for veterinary medicine.
Geary TG; Conder GA; Bishop B
Trends Parasitol; 2004 Oct; 20(10):449-55. PubMed ID: 15363437
[TBL] [Abstract][Full Text] [Related]
3. Target validation: linking target and chemical properties to desired product profile.
Wyatt PG; Gilbert IH; Read KD; Fairlamb AH
Curr Top Med Chem; 2011; 11(10):1275-83. PubMed ID: 21401506
[TBL] [Abstract][Full Text] [Related]
4. Abstracts of the 2nd COST B22 Congress on Drug Discovery and Development for Parasitic Diseases, Siena, Italy, 29 September-1 October 2005.
Parassitologia; 2005 Sep; 47 Suppl 1():3-128. PubMed ID: 16252442
[No Abstract] [Full Text] [Related]
5. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance in parasites: can we stay ahead of the evolutionary curve?
Sibley CH; Hunt SY
Trends Parasitol; 2003 Nov; 19(11):532-7. PubMed ID: 14580966
[No Abstract] [Full Text] [Related]
7. Resistance to antiparasitic drugs: the role of molecular diagnosis.
Sangster N; Batterham P; Chapman HD; Duraisingh M; Le Jambre L; Shirley M; Upcroft J; Upcroft P
Int J Parasitol; 2002 May; 32(5):637-53. PubMed ID: 11943235
[TBL] [Abstract][Full Text] [Related]
8. Current antiparasitic drug targets and a paradigm shift in discovery of new antiparasitic drugs and vaccines.
Tekwani BL
Curr Drug Targets; 2008 Nov; 9(11):921. PubMed ID: 18991603
[No Abstract] [Full Text] [Related]
9. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
10. Tropical and Subtropical Parasitic Diseases: Targets for a New Approach to Virtual Screening.
Yunta MJR; Dietrich RC
Mol Inform; 2019 Nov; 38(11-12):e1900052. PubMed ID: 31490642
[TBL] [Abstract][Full Text] [Related]
11. Early toxicity screening and selection of lead compounds for parasitic diseases.
Nogueira RC; Oliveira-Costa JF; de Sá MS; dos Santos RR; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):291-8. PubMed ID: 19275565
[TBL] [Abstract][Full Text] [Related]
12. Drug discovery and development for neglected parasitic diseases.
Renslo AR; McKerrow JH
Nat Chem Biol; 2006 Dec; 2(12):701-10. PubMed ID: 17108988
[TBL] [Abstract][Full Text] [Related]
13. Developing drugs for parasitic diseases.
Andreopoulos S
Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858
[No Abstract] [Full Text] [Related]
14. Recent Advances in Drug Discovery for Parasitic Diseases.
de Moraes J
Curr Top Med Chem; 2023; 23(9):711-712. PubMed ID: 37254528
[No Abstract] [Full Text] [Related]
15. Integrated dataset of screening hits against multiple neglected disease pathogens.
Nwaka S; Besson D; Ramirez B; Maes L; Matheeussen A; Bickle Q; Mansour NR; Yousif F; Townson S; Gokool S; Cho-Ngwa F; Samje M; Misra-Bhattacharya S; Murthy PK; Fakorede F; Paris JM; Yeates C; Ridley R; Van Voorhis WC; Geary T
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1412. PubMed ID: 22247786
[TBL] [Abstract][Full Text] [Related]
16. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics: identifying drug targets for parasitic diseases.
Cowman AF; Crabb BS
Trends Parasitol; 2003 Nov; 19(11):538-43. PubMed ID: 14580967
[No Abstract] [Full Text] [Related]
18. Target validation for drug discovery in parasitic organisms.
Jackson LK; Phillips MA
Curr Top Med Chem; 2002 May; 2(5):425-38. PubMed ID: 11966465
[TBL] [Abstract][Full Text] [Related]
19. Targeting histone acetylation/deacetylation in parasites: an update (2017-2020).
Fioravanti R; Mautone N; Rovere A; Rotili D; Mai A
Curr Opin Chem Biol; 2020 Aug; 57():65-74. PubMed ID: 32615359
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial chemistry as a new approach in antiparasitic drug discovery.
Link A
Parasitol Res; 2003 Jun; 90 Suppl 2():S86-90. PubMed ID: 12734752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
